February 14th, 2006 - Volume 20 - Issue 3
pp: N1-N2,317-481

Relationships between cellular immune responses and treatment outcomes with interferon and ribavirin in HIV/hepatitis C virus co-infection

Graham, Camilla S; Wells, Annalee; Liu, Tun; More

AIDS. 20(3):345-351, February 14th, 2006.

Interruption of antiretroviral therapy blunts but does not abrogate CD4 T-cell responses to interleukin-2 administration in HIV infected patients

Keh, Chris E; Shen, Jean M; Hahn, Barbara; More

AIDS. 20(3):361-369, February 14th, 2006.

Altered hepatic expression of SREBP-1 and PPARγ is associated with liver injury in insulin-resistant lipodystrophic HIV-infected patients

Lemoine, Maud; Barbu, Véronique; Girard, Pierre Marie; More

AIDS. 20(3):387-395, February 14th, 2006.

Pharmacokinetics, pharmacodynamics and safety of once-daily versus twice-daily dosing with enfuvirtide in HIV-infected subjects

Thompson, Melanie; DeJesus, Edwin; Richmond, Gary; More

AIDS. 20(3):397-404, February 14th, 2006.

Sustained control of viremia following therapeutic immunization in chronically HIV-1-infected individuals

Lévy, Yves; Durier, Christine; Lascaux, Anne-Sophie; More

AIDS. 20(3):405-413, February 14th, 2006.

Concise Communication

Major role of hepatitis B genotypes in liver fibrosis during coinfection with HIV

Lacombe, Karine; Massari, Véronique; Girard, Pierre-Marie; More

AIDS. 20(3):419-427, February 14th, 2006.

Mode of delivery and postpartum HIV-1 disease progression: The Women and Infants Transmission Study

Navas-Nacher, Elena L; Read, Jennifer S; Leighty, Robert M; More

AIDS. 20(3):429-436, February 14th, 2006.


CD4 cell recovery in treated HIV-2-infected adults is lower than expected: results from the French ANRS CO5 HIV-2 cohort

Matheron, Sophie; Damond, Florence; Benard, Antoine; More

AIDS. 20(3):459-462, February 14th, 2006.

1 2 3 4 5